Reimbursement and use of intensity-modulated radiation therapy for prostate cancer

The use of intensity-modulated radiation therapy (IMRT) for prostate cancer increased through the mid-2000s, in association with acquisition of the devices by large urology groups. More recently, reimbursement for IMRT in the office setting (generally representing freestanding facilities owned by ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahinian, Vahakn B., Kaufman, Samuel R., Yan, Phyllis, Herrel, Lindsey A., Borza, Tudor, Hollenbeck, Brent K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484181/
https://www.ncbi.nlm.nih.gov/pubmed/28640073
http://dx.doi.org/10.1097/MD.0000000000006929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484181/
https://www.ncbi.nlm.nih.gov/pubmed/28640073
http://dx.doi.org/10.1097/MD.0000000000006929

Ejemplares similares